Welcome to the UPhA Web-site!
This is the place to find resources and valuable information about the practice of pharmacy and the role of this Association in working to create a better future for pharmacy professionals and their patients.
In keeping with our Mission Statement, UPhA strives to meet its member's needs through 3 main focus points: Legislative Support and Advocacy Communication, and Education. This new site has many advantages to make these goals a reality. Besides a more streamlined look, our pages now contain more beneficial information regarding Legislative Action in respect to our Pharmacy Practice Act - and this will continue to grow and expand before, during and after our regular sessions.
We want you to get involved with our Association. Members or prospective members can pay for Membership Dues right here on our site. And those wishing to attend our Conventions and Conferences can avoid the paperwork and register and pay for events right here on line. We invite you to explore what we have to offer, and we welcome your comments.
Reid L. Barker
Executive Director
435-462-5323 |
F.A.Q
Frequently Asked Questions |
Please join us at our Summer C.E. in Sandy Convention
I m p o r t a n t N e w s
Medicaid Tamper Resistant Prescription Law Became Effective on April 1
As we have previously communicated, the Medicaid Tamper Resistant Prescription requirements went into effect April 1, 2008. The law applies only to written prescriptions for covered outpatient drugs; prescriptions that are transmitted from the prescriber to the pharmacy verbally, by fax, or through an e-prescription are not impacted by the statute, and so those methods may be used as alternatives to a written prescription. The law applies whenever Medicaid pays any portion of the cost of a prescription.
For Full Story, Click Here
The Fifth Circuit Court of Appeals today ruled in the so-called Midland Case
– Medical Center Pharmacy et al. v. Mukasey.
We are still analyzing the decision, but it appears the court has ruled that compounded drugs are "new drugs" but that they are conditionally exempt from the Food, Drug, and Cosmetic Act. The conditions for exemption of human drugs are set forth in Section 503A of the Federal Food Drug and Cosmetic Act (FDCA) as added by FDAMA, and the conditions for exemption of animal drugs are set forth in the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA).
For Full Story, Click Here
|
